Navigation Links
PharmaNet's Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics

PRINCETON, N.J., Dec. 13, 2010 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.

Clinical studies require the handling and management of massive amounts of data. Many aspects of these processes still remain largely manual. With the launch of these two new technology platforms, PharmaNet will accelerate these processes, provide rapid data handling and eliminate potential transcription errors, as data is processed through different software tools. The data can be verified on-line and real-time information about the clinical study can be obtained in validated systems that provide the necessary audit trail features and compliance with 21CFR Part 11 standards.

"The investments in Initiator and PKS will help us to accelerate the availability of data to our clients and will help to further improve data integrity," said Riaz Bandali, President, Early Stage Development. "The implementation of these systems demonstrates our strong commitment to client service, study participant safety and quality in everything we do."

During 2010, the Company made significant investments in the implementation of PKS™, WinNonlin® and WinNonlin® Autopilot™, a complete PK/PD data management and reporting solution. This suite of products, provided by Pharsight, is used by several major pharmaceutical companies. PharmaNet is the first full-service CRO to implement PKS as part of its clinical pharmacology service offerings. This centralized data repository houses all PK/PD data, analysis and objects related to a study and seamlessly interfaces with the Company's laboratory information system and other CDISC formatted data sources.  Final PK/PD data and analysis are flexibly produced in standard or customized reports.

To enhance the processing and monitoring of study participants and study data in its Phase I clinical operations, PharmaNet has also implemented Initiator™, a software system specifically built for the efficient conduct of Phase I studies. The implementation of this platform enables rapid study set-up, automated CRF generation and better study recruitment and communication tools for general and special populations. Mobile workstations allow for rapid data entry and data is captured directly using bar codes and interfaces to medical equipment, such as blood pressure monitors. The Initiator platform also interfaces with the Company's LIMS, as well as its diagnostic laboratory software and investigational drug management system.

"The combination of diversified experience, access to special populations and efficient, quality driven business, clinical and reporting systems places PharmaNet at the forefront of Phase I clinical development," added Mr. Bandali.

About PharmaNet Development Group, Inc.PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit

Pharsight, PKS, WinNonlin, WinNonlin Autopilot are trademarks or registered trademarks or Tripos, L.P. Initiator is a trademark of Perceptive Informatics. Contact: Anne-Marie HessPhone:   (609) 951-6842E-mail:

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
2. ECRI Institute Releases Top 10 Health Technology Hazards for 2011
3. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
4. China Medical Technologies Announces its Subsidiaries, GP Medical and Beijing Yuande, Ranked 12th and 415th, respectively, in Deloitte Technology Fast 500 Asia Pacific 2010 Program
5. New Report Indicates VERILAST™ Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials
6. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
7. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
8. BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States
9. Encisions Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress
10. Reportlinker Adds Global Agricultural Biotechnology Industry
11. Richter Rubber Technology Selects Vystar Corporations Vytex® Natural Rubber Latex (NRL) for Products to Launch This Year
Post Your Comments:
(Date:12/1/2015)... December 1, 2015 Biovicas ... Study Group (IBCSG, Bern ) ... i en klinisk studie av palbociclib, ett nytt ... --> Studien, med namn PYTHIA, kommer följa ... läkemedel i kombination med palbociclib, som tillhör klassen ...
(Date:11/30/2015)... Dec. 1, 2015 Researchers have developed software ... part thickness and checks for motion, positioning and beam ... study presented today at the annual meeting of the ... (RSNA). Steven Don , M.D., associate professor ... School of Medicine in St. Louis, Mo. ...
(Date:11/30/2015)... TOKYO , 1. Dezember 2015 /PRNewswire/ ... größte Messe und Konferenz für Entwicklung ... 20. bis 22. April 2016 in ... Foto:- ... Logo: Logo: ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won ... order will be from the China Disabled Persons’ Federation, a central government association, for ... for children and adults suffering from severe and profound hearing loss . The ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., ... Provider (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled the ... Center solutions targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Trevor and Taylor Crabb have unveiled an exciting ... chance to represent the United States. This hybrid crowdfunding campaign is designed ... their journey in addition to offering corporate sponsors with some great marketing deliverables with ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National Association of Professional ... VIP Woman of the Year Circle. She is recognized with this prestigious distinction for ... for professional women, boasting more than 850,000 members and over 200 operating Local Chapters. ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
Breaking Medicine News(10 mins):